Crossmark

A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors

Crossref DOI link: https://doi.org/10.1007/s00280-016-3167-7

Published Online: 2016-10-15

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bailey, Hanna

McPherson, Jordan P.

Bailey, Erin B.

Werner, Theresa L.

Gupta, Sumati

Batten, Julia

Reddy, Guru

Bhat, Gajanan

Sharma, Sunil

Agarwal, Neeraj
Funding

Funding for this research was provided by:

Topotarget

Spectrum Pharmaceuticals
License Information

License valid from 2016-10-15